The 18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)

TheBody.com/TheBodyPRO.com covers The 18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)

TheBodyPRO.com's independent coverage of CROI 2011 is not associated with the conference itself. Please note that all links on this page will take you to articles on TheBodyPRO.com, TheBody.com's sister site for health care professionals. TheBodyPRO.com is an independent Web site not associated with this conference.

CROI 2011 Wrap-Up: Taking Research Into Practice Joel Gallant, M.D., takes a step back from the presented research at CROI to discuss the practical implications of recent developments in the field. In this interview, he speaks about biomedical HIV prevention methods, the dry drug development pipeline (particularly for multidrug-resistant patients), the unanswered questions about inflammation, and the "when to start treatment" question. He also discusses the importance of ensuring that patients keep, and share, their medical records. More Top Stories: Really Rapid Review of CROI 2011 -- and No CROI 2012 Dates Zinc Fingers and Gene Therapies for HIV: Mimicking the Cured Berlin Patient? The Slow Decline: An Update on Neurological Complications Among People With HIV Complete Index of Coverage

*Could MicroRNA Be the Next Great Frontier in HIV/AIDS Treatment -- and* Prevention? MicroRNA (miRNA) has been found to play a critical role in some viral infections. In this video interview, Bryan Cullen, Ph.D., reviews our knowledge to date about miRNA and discusses its potential application in HIV. More Highlights:** Zinc Fingers and Gene Therapies for HIV: Mimicking the Cured Berlin Patient? The Slow Decline: An Update on Neurological Complications Among People With HIV Virologic Failure on HIV Treatment 40% More Likely Among African Americans Than Whites, Study Finds Lower Limb Fat, Higher Belly Fat Associated With Mortality in People With HIV; BMI Measurements Questioned Much of HIV Treatment-Related Bone Loss Occurs Early in Therapy and Is Related to Immune Recovery, Study Finds More		Studies in Post-Menopausal Women Reveal Potentially Higher Biological HIV Risk, as Well as Possible Tenofovir Concerns This week, two studies shone a little light into the dark corners of HIV research in aging women. One suggests that post-menopausal women may be at a biologically higher risk for HIV; the other found potentially increased levels of tenofovir in older women. More Highlights: Vaginal Tenofovir-Based Microbicide Gel Doesn't Quite Measure Up When Used Rectally, Study Shows Q and A: Moving PrEP From Promising Trial Result to Practical, Public Health Prevention Intervention? Effective HIV Prevention Programs in the U.S. Scientists at Retrovirus Conference Present Findings on Microbicide Gel, Truvada, Male Circumcision, ART Care by Nurses AIDS Gel Shown to Protect Anal Tissue From HIV More

TheBodyPRO.com's coverage of the 18th Conference on Retroviruses and Opportunistic Infections (CROI 2011) will include summaries of a wide array of individual studies and presentations, as well as discussions featuring study authors and leading HIV clinicians/researchers.

For more information on CROI 2011, please visit the conference's Web site. You may also view the conference program online.

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Home

Choose a Topic:

Previous Conferences

New! TheBody.com App

My Health Tracker

Medication and Health Reminders

Assess Your Risk for HIV

U.S. ASO Finder

The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.